Crossmark

Dual CAR-T cell therapy targeting CD19 and BCMA as a novel opportunity for immune reset in systemic lupus erythematosus

Crossref DOI link: https://doi.org/10.1038/s41423-026-01403-0

Published Online: 2026-05-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Haubner, Sascha https://orcid.org/0000-0002-5348-1456
Sadelain, Michel https://orcid.org/0000-0002-9031-8025
License Information

Text and Data Mining valid from 2026-05-06

Version of Record valid from 2026-05-06
More Information

Article History

Received: 25 February 2026

Accepted: 26 February 2026

First Online: 6 May 2026

Competing interests

: The authors declare no competing interests.